Entities / Company
Acacia Research.
patent enforcement entity
- Reports this week
- 0
- Active events
- 0
- Connections
- 10
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Acacia Research appointed Michael Zambito as CFO on June 24, 2025.Speculative1 report
-
Acacia Research released financial figures for the trailing 12-month period on August 7, 2025, involving TTM, with industry comparison made in the US.Some support1 report
-
Acacia Research operates businesses across various regions worldwide, and Relmada Therapeutics is a company in the United States.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Acacia Research this week
News at the entities that move Acacia Research most-
Renaissance Technologies TransactionalRenaissance Technologies raised its stake in shares of Star Equity Holdings, Inc. on August 25, 2026.Moves Acacia Research
-
Nasdaq Shared contextMillerKnoll shares traded on Nasdaq and Benchmark upgraded its stock rating on October 31, 2026.Moves Acacia Research
Connections
The 3 strongest of 10, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Renaissance Technologies Transactional
Renaissance Technologies raised its stake in Acacia Research on September 16, 2026.
-
Rocket Companies Mentioned together
The entities are co-mentioned in articles comparing them as finance companies.
-
Nasdaq Shared context
Acacia Research is listed on the Nasdaq stock exchange.
History
Events by the month they beganSeptember 2026
2 eventsJune 2026
3 events- Acacia Research appointed Michael Zambito as CFO on June 24, 2025.
- Acacia Research released financial figures for the trailing 12-month period on August 7, 2025, involving TTM, with industry comparison made in the US.
- Acacia Research operates businesses across various regions worldwide, and Relmada Therapeutics is a company in the United States.